Feb 4 (Reuters) - Pfizer Inc PFE.N:
PFIZER REPORTS STRONG FULL-YEAR 2024 RESULTS AND REAFFIRMS 2025 GUIDANCE
PFIZER: ON TRACK TO DELIVER OVERALL NET COST SAVINGS OF APPROXIMATELY $4.5 BILLION BY END OF 2025
PFIZER: REMAIN CONFIDENT IN OUR ABILITY TO RETURN TO PRE-PANDEMIC OPERATING MARGINS IN COMING YEARS
PFIZER: FOURTH-QUARTER 2024 COMIRNATY REVENUE OF $3.4 BILLION
PFIZER: FOURTH-QUARTER 2024 PAXLOVID REVENUE OF $727 MILLION
FY2025 EARNINGS PER SHARE VIEW $2.93 -- LSEG IBES DATA
FY2025 REVENUE VIEW $63.01 BILLION -- LSEG IBES DATA
PFIZER -TOTAL NON-CASH INTANGIBLE ASSET IMPAIRMENT CHARGES OF $2.9 BILLION TAKEN IN Q4 2024 DUE TO CHANGES IN DEVELOPMENT PLANS
Source text: ID:nBw3tRr7Da
Further company coverage: PFE.N